Sunday January 26, 2020

‘We don’t pay patients for what we do’

Anne Jones of Genomics Medicine Ireland wants your DNA, and insists it will be ‘rigorously’ protected

17th March, 2019
Anne Jones, chief executive at GMI Picture: Bryan Meade

Medical research company Genomics Medicine Ireland (GMI) will go for an initial public offering within the next two years.

Based in Dublin, GMI was acquired by Chinese genomics specialists WuXi Nextcode last November. The value of the deal was not disclosed, but the company committed to investing $400 million to GMI’s plan to sequence the genomes of 400,000 people in Ireland.

It costs about $2,500 for each genome sequenced, so GMI’s plan to map the...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

The HSE has a funding crisis. Unless it is solved, the Sláintecare health reform programme cannot be implemented

Tony O'Brien | 21 hours ago

After two crashes and 346 deaths, the aircraft manufacturer’s new 737 Max has been grounded. It has since emerged that the plane was rushed through production, with pilots kept in the dark about a new control system, and no one seems be sure when it will be ready for takeoff again

Barry J Whyte | 21 hours ago

Allowing our super-rich to go under the radar ensures that the wealth gap in Ireland is just as entrenched as in other parts of the world

Vincent Boland | 21 hours ago